Takenaka, T <br/><br/>
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.  [electronic resource] 

 -  Japanese journal of clinical oncology  Oct 1999 
 - 485-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0368-2811 
<br/><br/><label>Standard No.: </label>10.1093/jjco/29.10.485  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Prednisone--administration & dosage<br/>Survival Rate<br/>Vincristine--administration & dosage